These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 18499674)

  • 1. Influences of the N700S thrombospondin-1 polymorphism on protein structure and stability.
    Carlson CB; Liu Y; Keck JL; Mosher DF
    J Biol Chem; 2008 Jul; 283(29):20069-76. PubMed ID: 18499674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations targeting intermodular interfaces or calcium binding destabilize the thrombospondin-2 signature domain.
    Carlson CB; Gunderson KA; Mosher DF
    J Biol Chem; 2008 Oct; 283(40):27089-99. PubMed ID: 18682400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunochemical analysis of the structure of the signature domains of thrombospondin-1 and thrombospondin-2 in low calcium concentrations.
    Annis DS; Gunderson KA; Mosher DF
    J Biol Chem; 2007 Sep; 282(37):27067-27075. PubMed ID: 17620335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A polymorphism in thrombospondin-1 associated with familial premature coronary heart disease causes a local change in conformation of the Ca2+-binding repeats.
    Hannah BL; Misenheimer TM; Annis DS; Mosher DF
    J Biol Chem; 2003 Mar; 278(11):8929-34. PubMed ID: 12643280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions among stalk modules of thrombospondin-1.
    Liu Y; Mosher DF
    J Biol Chem; 2009 Oct; 284(42):28563-70. PubMed ID: 19706610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A polymorphism in thrombospondin-1 associated with familial premature coronary artery disease alters Ca2+ binding.
    Hannah BL; Misenheimer TM; Pranghofer MM; Mosher DF
    J Biol Chem; 2004 Dec; 279(50):51915-22. PubMed ID: 15456750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the calcium-rich signature domain of human thrombospondin-2.
    Carlson CB; Bernstein DA; Annis DS; Misenheimer TM; Hannah BL; Mosher DF; Keck JL
    Nat Struct Mol Biol; 2005 Oct; 12(10):910-4. PubMed ID: 16186819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium-induced conformational changes of Thrombospondin-1 signature domain: implications for vascular disease.
    Gupta A; Agarwal R; Singh A; Bhatnagar S
    J Recept Signal Transduct Res; 2017 Jun; 37(3):239-251. PubMed ID: 27485292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical characterization of the signature domains of thrombospondin-4 and thrombospondin-2.
    Misenheimer TM; Mosher DF
    J Biol Chem; 2005 Dec; 280(50):41229-35. PubMed ID: 16246837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombospondin-2 polymorphism is associated with a reduced risk of premature myocardial infarction.
    Boekholdt SM; Trip MD; Peters RJ; Engelen M; Boer JM; Feskens EJ; Zwinderman AH; Kastelein JJ; Reitsma PH
    Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):e24-7. PubMed ID: 12482844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of a thrombospondin C-terminal fragment reveals a novel calcium core in the type 3 repeats.
    Kvansakul M; Adams JC; Hohenester E
    EMBO J; 2004 Mar; 23(6):1223-33. PubMed ID: 15014436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions among the epidermal growth factor-like modules of thrombospondin-1.
    Liu Y; Annis DS; Mosher DF
    J Biol Chem; 2009 Aug; 284(33):22206-22212. PubMed ID: 19531495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms A387P in thrombospondin-4 and N700S in thrombospondin-1 perturb calcium binding sites.
    Stenina OI; Ustinov V; Krukovets I; Marinic T; Topol EJ; Plow EF
    FASEB J; 2005 Nov; 19(13):1893-5. PubMed ID: 16148025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction.
    Narizhneva NV; Byers-Ward VJ; Quinn MJ; Zidar FJ; Plow EF; Topol EJ; Byzova TV
    J Biol Chem; 2004 May; 279(20):21651-7. PubMed ID: 15007078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structures of thrombospondins.
    Carlson CB; Lawler J; Mosher DF
    Cell Mol Life Sci; 2008 Mar; 65(5):672-86. PubMed ID: 18193164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of thrombospondin type 3 repeats in bacterial outer membrane protein A reveals its intra-repeat disulfide bond-dependent calcium-binding capability.
    Dai S; Sun C; Tan K; Ye S; Zhang R
    Cell Calcium; 2017 Sep; 66():78-89. PubMed ID: 28807152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Function-blocking antithrombospondin-1 monoclonal antibodies.
    Annis DS; Murphy-Ullrich JE; Mosher DF
    J Thromb Haemost; 2006 Feb; 4(2):459-68. PubMed ID: 16420580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The crystal structure of the signature domain of cartilage oligomeric matrix protein: implications for collagen, glycosaminoglycan and integrin binding.
    Tan K; Duquette M; Joachimiak A; Lawler J
    FASEB J; 2009 Aug; 23(8):2490-501. PubMed ID: 19276170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The calcium binding properties and molecular organization of epidermal growth factor-like domains in human fibrillin-1.
    Handford P; Downing AK; Rao Z; Hewett DR; Sykes BC; Kielty CM
    J Biol Chem; 1995 Mar; 270(12):6751-6. PubMed ID: 7896820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and characterization of novel thrombospondin 1 type I repeat fusion proteins.
    Qabar AN; Bullock J; Matej L; Polverini P
    Biochem J; 2000 Feb; 346 Pt 1(Pt 1):147-53. PubMed ID: 10657251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.